Luszczak M
Department of Emergency Medicine, Darnall Army Community Hospital, Fort Hood, Texas 76544, USA.
Am Fam Physician. 2001 Oct 1;64(7):1219-26.
A practice guideline for the management of febrile infants and children younger than three years of age sparked controversy when it was published in 1993. Surveys indicate that many office-based physicians do not agree with recommendations for venipuncture and bladder catheterization in nontoxic febrile children, and that many employ watchful waiting rather than empiric antibiotic therapy. Surveys of parents note a preference for less testing and treatment. More aggressive management may be appropriate in febrile infants younger than three months old; however, criteria have been proposed to identify infants older than one month who are at low risk for serious bacterial infection. Because of widespread vaccination against Haemophilus influenzae infection, Streptococcus pneumoniae has become the cause of most cases of bacteremia. The risk of serious bacterial infection is greater in younger children and in those with higher temperatures and white blood cell counts. Controversy persists regarding the age, temperature and white blood cell count values that serve as indications for further evaluation or empiric antibiotic therapy.
1993年发布的一份针对3岁以下发热婴幼儿的治疗指南引发了争议。调查显示,许多门诊医生不同意对无中毒症状的发热儿童进行静脉穿刺和膀胱插管的建议,许多医生采用观察等待而非经验性抗生素治疗。对家长的调查表明,他们更倾向于减少检查和治疗。对于3个月以下的发热婴儿,可能需要更积极的治疗;然而,已经提出了一些标准来识别1个月以上患严重细菌感染风险较低的婴儿。由于针对流感嗜血杆菌感染的广泛疫苗接种,肺炎链球菌已成为大多数菌血症病例的病因。年幼儿童以及体温和白细胞计数较高的儿童发生严重细菌感染的风险更大。关于作为进一步评估或经验性抗生素治疗指征的年龄、体温和白细胞计数值,争议仍然存在。